RISK AND PREDICTORS OF LIVER DECOMPENSATION IN COMPENSATED CIRRHOSIS WITH CLINICALLY SIGNIFICANT PORTAL HYPERTENSION: MAFLD-RELATED VS NON-MAFLD RELATED CIRRHOSIS

被引:0
|
作者
Wong, Yu Jun
Chen, Kaina
Tan, Yu Bin
Tay, Shu Wen
Teh, Kevin Kim Jun
Kumar, Rahul
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su340
引用
收藏
页码:S854 / S854
页数:1
相关论文
共 50 条
  • [1] METABOLOMICS IMPROVES THE PREDICTION OF RISK OF DECOMPENSATION OR LIVER RELATED DEATH IN PATIENTS WITH COMPENSATED CIRRHOSIS AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
    Maria Nicoara-Farcau, Oana
    Jose Lozano, Juan
    Sidorova, Julia
    Villanueva Sanchez, Candido
    Albillos, Agustin
    Genesca, Joan
    Luis Calleja, Jose
    Aracil, Carles
    Banares, Rafael
    Maria Morillas, Rosa
    Poca Sans, Maria
    Penas, Beatriz
    Augustin, Salvador
    Perez-Campuzano, Valeria
    Hernandez-Gea, Virginia
    Abraldes, Juan G.
    Alvarado Tapias, Edilmar
    Torres, Ferran
    Bosch, Jaime
    Carlos Garcia-Pagan, Juan
    HEPATOLOGY, 2022, 76 : S155 - S156
  • [2] Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
    Ziwei Guo
    Dongjie Wu
    Runhan Mao
    Ziang Yao
    Qingjuan Wu
    Wenliang Lv
    Scientific Reports, 15 (1)
  • [3] Validation of Baveno VI and expanded Baveno VI criteria to identify high-risk varices in patients with MAFLD-related compensated cirrhosis
    Zheng, Kenneth I.
    Liu, Chuan
    Li, Jia
    Zhao, Lili
    Zheng, Ming-Hua
    Wang, Fengmei
    Qi, Xiaolong
    JOURNAL OF HEPATOLOGY, 2020, 73 (06) : 1571 - 1573
  • [4] BACTERIAL INFECTIONS IN PATIENTS WITH COMPENSATED CIRRHOSIS AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION: IMPLICATIONS ON THE RISK OF DEVELOPING DECOMPENSATION AND ON SURVIVAL.
    Villanueva, Candid
    Albillos, Agustin
    Genesca, Joan
    Carlos Garcia-Pagan, Juan
    Luis Calleja, Jose
    Aracil, Carles
    Banares Canizares, Rafael
    Morillas, Rosa
    Poca Sans, Maria
    Penas, B.
    Augustin, Salvador
    Abraldes, Juan G.
    Alvarado Tapias, Edilmar
    Torres, Ferran
    Bosch, Jaime
    HEPATOLOGY, 2019, 70 : 36A - 37A
  • [5] Risk assessment of clinically significant portal hypertension by means of hepatosplenic volumetry in compensated cirrhosis
    Romero Cristobal, Mario
    Clemente, Ana
    Ramon Botella, Enrique
    Ortega, Olga
    Velilla, Elena
    Matilla, Ana M.
    Marquez, Laura
    Magdalena Salcedo, Maria
    Alonso, Sonia
    Vega Catalina, Maria
    Fernandez, Ainhoa
    Diaz Fontela, Fernando
    Ibanez, Luis
    Rincon, Diego
    Banares, Rafael
    JOURNAL OF HEPATOLOGY, 2020, 73 : S742 - S742
  • [6] Indocyanine Green Clearance as a Marker of Decompensation and Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
    Turco, Laura
    Azzaroli, Francesco
    Buonfiglioli, Federica
    Lisotti, Andrea
    Cecinato, Paolo
    Calvanese, Claudio
    Lodato, Francesca
    Montagnani, Marco
    Golfieri, Rita
    Colecchia, Antonio
    Festi, Davide
    Mazzella, Giuseppe
    GASTROENTEROLOGY, 2011, 140 (05) : S958 - S958
  • [7] INDOCYANINE GREEN CLEARANCE AS A MARKER OF DECOMPENSATION AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS
    Turco, L.
    Azzaroli, F.
    Buonfiglioli, F.
    Lisotti, A.
    Cecinato, P.
    Montagnani, M.
    Calvanese, C.
    Lodato, F.
    Golfieri, R.
    Colecchia, A.
    Festi, D.
    Mazzella, G.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S380 - S380
  • [8] INDOCYANINE GREEN CLEARANCE AS A MARKER OF DECOMPENSATION AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS
    Turco, L.
    Azzaroli, F.
    Buonfiglioli, F.
    Simoni, P.
    Lisotti, A.
    Cecinato, P.
    Calvanese, C.
    Lodato, F.
    Montagnani, M.
    Golfieri, R.
    Colecchia, A.
    Festi, D.
    Mazzella, G.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S174 - S174
  • [9] PREVALENCE AND PROGNOSIS OF PATIENTS WITH MAFLD-RELATED CIRRHOSIS AFTER ICU HOSPITALIZATION IN FRANCE: A MONOCENTRIC PROSPECTIVE STUDY
    Lherault, Guillaume
    Sultanik, Philippe
    Ratziu, Vlad
    Pais, Raluca
    Mouri, Sarah
    Bouzbib, Charlotte
    Damais, Dominique Thabut
    Marika, Rudler
    HEPATOLOGY, 2023, 78 : S1031 - S1031
  • [10] Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
    Degasperi, Elisabetta
    Anolli, Maria Paola
    Renteria, Sara Colonia Uceda
    Sambarino, Dana
    Borghi, Marta
    Perbellini, Riccardo
    Scholtes, Caroline
    Facchetti, Floriana
    Loglio, Alessandro
    Monico, Sara
    Fraquelli, Mirella
    Costantino, Andrea
    Ceriotti, Ferruccio
    Zoulim, Fabien
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2022, 77 (06) : 1525 - 1531